M-Drol Lawsuit Filed Over Liver Damage From Dietary Supplement

Two men are suing the makers of M-Drol and P-Plex, two muscle-building dietary supplements sold online, which they allege caused them to suffer liver damage.

The product liability lawsuits were filed on November 17 on behalf of Jesse Woods and Heath Stevison in Galveston County District Court in Texas against Competitive Edge Labs, the manufacturer, and TF Supplements, which distributed the products. According to a report by Iron Magazine, the claims allege that the dietary supplements are defective and unreasonably dangerous, resulting in both men suffering liver damage.

Both plaintiffs say they were hospitalized with signs of liver failure after taking M-Drol for several weeks in an effort to put on muscle mass. Woods also said he took P-Plex, another Competitive Edge Labs supplement, which also allegedly contributed to his injuries. The products were bought online through Galveston-based TF Supplements.

The M-Drol lawsuits say Woods and Stevison suffered permanent liver damage from taking the supplement, and have accused the defendants of negligence, product liability and breach of warranty. TF Galveston has stopped selling M-Drol.

Competitive Edge Labs’ website has a notice that it has ceased to sell M-Drol and P-Plex.

Dietary supplements have come under increased scrutiny in recent months by federal regulators in the wake of a Hydroxycut recall issued in May, after FDA identified a number of reports where users suffered serious and potentially life-threatening liver damage. In July, the FDA warned consumers not to take dietary supplements which contained ingredients identified as steroids. The agency recommended that anyone taking dietary supplements containing steroids should immediately see a doctor if they showed signs of liver problems.

A number of Hydroxycut lawsuits have been filed throughout the country against the maker of that supplement, Iovate Health Sciences. In October, all federal lawsuits were consolidated as part of a multidistrict litigation (MDL) for pretrial proceedings in the U.S. District Court for the Southern District of California. All of the cases in the Hydroxycut litigation involve allegations that Iovate Health Sciences failed to adequately research their weight-loss products or warn about potential side effects prior to issuing the Hydroxycut recall.